Evidence map›Paper›PMID 35493654›Full record

ArticleRSC advances2020

A new Bi

Zhongmin Wang, Xinli Tian, Dong Sun, Penghui Cao, Mengkui Ding, Yuhao Li, Ning Guo, Ruizhuo Ouyang, Yuqing Miao

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Hydrangea-like TiOMikrochimica acta · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Zhongmin WangInstitute of Bismuth Science, The University of Shanghai for Science and Technology Shanghai 200093 China ouyangrz@usst.edu.cn.
Xinli TianInstitute of Bismuth Science, The University of Shanghai for Science and Technology Shanghai 200093 China ouyangrz@usst.edu.cn.
Dong SunSchool of Chemistry and Chemical Engineering, Henan Normal University Xinxiang 453007 China.
Penghui CaoInstitute of Bismuth Science, The University of Shanghai for Science and Technology Shanghai 200093 China ouyangrz@usst.edu.cn.
Mengkui DingInstitute of Bismuth Science, The University of Shanghai for Science and Technology Shanghai 200093 China ouyangrz@usst.edu.cn.
Yuhao LiInstitute of Bismuth Science, The University of Shanghai for Science and Technology Shanghai 200093 China ouyangrz@usst.edu.cn.
Ning GuoInstitute of Bismuth Science, The University of Shanghai for Science and Technology Shanghai 200093 China ouyangrz@usst.edu.cn.
Ruizhuo OuyangInstitute of Bismuth Science, The University of Shanghai for Science and Technology Shanghai 200093 China ouyangrz@usst.edu.cn.ORCID https://orcid.org/0000-0003-0562-7569
Yuqing MiaoInstitute of Bismuth Science, The University of Shanghai for Science and Technology Shanghai 200093 China ouyangrz@usst.edu.cn.
University of Shanghai for Science and Technology · CNXinxiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

By doping molybdenum (Mo) into bismuth oxide (Bi

Identifiers

PMID35493654
PMCPMC9052421
OpenAlexW3020334338

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.